Patent · US Active

ETP derivatives

US10246471B2 · kind B2 · utility

0Cited by
4References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 27, 2017
Grant dateApr 2, 2019
Priority date—
Expiry dateOct 27, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, is the synthesis of ETP derivatives. The uses of the ETP derivatives described herein include treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.